SQSTM1 Protein (p62/Sequestosome-1)

Pathway Diagram

flowchart TD
    N0["SQSTM1"]
    N1["NFE2L2"]
    N0 -->|"activates"| N1
    N2["LC3"]
    N2 -->|"activates"| N0
    N3["KEAP1"]
    N3 -->|"activates"| N0
    N4["MTOR"]
    N0 -->|"activates"| N4
    N5["P62"]
    N0 -->|"associated with"| N5
    N0 -->|"activates"| N5
    N6["NRF2"]
    N0 -->|"activates"| N6
    N5 -->|"activates"| N0
    N0 -->|"regulates"| N5
    N7["BECN1"]
    N7 -->|"activates"| N0
    N4 -->|"activates"| N0
    N0 -->|"encodes"| N5

Overview

SQSTM1, commonly known as p62 or sequestosome-1, is a ubiquitously expressed multifunctional protein encoded by the SQSTM1 gene located on chromosome 5q35. With a molecular weight of approximately 62 kDa, p62 functions as a critical cellular hub protein that coordinates multiple signaling pathways and protein quality control mechanisms. The protein was initially identified for its role in receptor-mediated signaling and subsequently recognized as a key component of the autophagic-ubiquitin-proteasome system (AUPS). p62 serves as an essential scaffold and adaptor protein that bridges ubiquitinated protein substrates with the autophagy machinery, making it a crucial regulator of cellular homeostasis and stress responses.

Function and Biology

p62 contains several functionally distinct domains that enable its role as a central signaling coordinator. The protein harbors an N-terminal Phox and Bem1p (PB1) domain that mediates protein-protein interactions through homo-oligomerization and interactions with other PB1-containing proteins like PKC and NBR1. The central region contains a zinc finger (ZZ) domain and an ubiquitin-associated (UBA) domain, with the latter conferring high-affinity binding to polyubiquitin chains. The C-terminal contains an ubiquitin-interacting motif (UIM) and a nuclear localization signal (NLS).

p62 functions primarily as an adapter protein that recognizes polyubiquitinated cargo—proteins tagged with lysine-63 (K63)-linked ubiquitin chains—and delivers them to the proteasome or autophagosome for degradation. This selective autophagy process involves p62 interacting with LC3 (light chain 3) and GABARAP proteins on autophagosome membranes through an LC3-interaction region (LIR) motif, effectively sequestering tagged proteins. Additionally, p62 participates in the NF-κB signaling pathway by interacting with kinase complexes and modulating inflammatory responses. The protein also regulates mammalian target of rapamycin (mTOR) signaling, which controls cellular growth and autophagy induction.

Role in Neurodegeneration

p62 accumulation is a hallmark feature of multiple neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease, and frontotemporal dementia. In these conditions, p62-positive inclusions frequently colocalize with pathological protein aggregates such as amyloid-beta, tau, alpha-synuclein, and TDP-43. The accumulation of p62 reflects impaired protein clearance mechanisms and serves as a biomarker for autophagy dysfunction. Mutations in SQSTM1, particularly in the UBA domain, are associated with familial ALS and Paget’s disease of bone, establishing a direct genetic link between p62 dysfunction and neurodegeneration.

Molecular Mechanisms

In neurodegenerative conditions, defective autophagy flux leads to p62 accumulation because the protein is itself an autophagy substrate that undergoes selective degradation when autophagy functions properly. Impaired p62 clearance indicates bottlenecks in the autophagy pathway, whether during autophagosome formation, maturation, or fusion with lysosomes. Furthermore, excess p62 can perpetuate neurotoxicity through several mechanisms: it amplifies mTOR signaling, inhibits autophagy induction through its interaction with Keap1 and Nrf2 (affecting antioxidant response), and promotes NF-κB-mediated neuroinflammation. Additionally, pathological protein aggregates sequester p62, reducing its availability for normal functions and creating a vicious cycle of impaired protein quality control.

Clinical and Research Significance

p62 serves as both a diagnostic marker and a therapeutic target in neurodegeneration research. Cerebrospinal fluid and serum p62 levels are emerging biomarkers for monitoring disease progression and autophagy dysfunction in neurodegenerative diseases. The protein represents a potential therapeutic intervention point, with research exploring strategies to enhance p62-mediated clearance through autophagy induction or to modulate its signaling functions. Genetic studies linking SQSTM1 mutations to disease have illuminated protein quality control mechanisms in neuronal vulnerability.

Related Entities

• LC3 (MAP1LC3B): Primary autophagosomal marker that interacts with p62

• NBR1: Neighbor of BRCA1 gene product; related selective autophagy receptor

• TDP-43: RNA-binding protein whose aggregates accumulate with p62 in ALS

• Alpha-synuclein: Parkinson’s disease-related protein that accumulates with p62

• mTOR: Nutrient-sensing kinase regulated by p62

• Keap1: Negative regulator of Nrf2 antioxidant pathway; p62 substrate

• Proteasome: Alternative degradation pathway coordinated with autophagy

Pathway Diagram

The following diagram shows the key molecular relationships involving SQSTM1 Protein (p62/Sequestosome-1) discovered through SciDEX knowledge graph analysis:

graph TD
    KEAP1["KEAP1"] -->|"activates"| SQSTM1["SQSTM1"]
    MITOPHAGY["MITOPHAGY"] -->|"activates"| SQSTM1["SQSTM1"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"associated with"| SQSTM1["SQSTM1"]
    AUTOPHAGY["AUTOPHAGY"] -->|"associated with"| SQSTM1["SQSTM1"]
    MTOR["MTOR"] -->|"activates"| SQSTM1["SQSTM1"]
    NEURODEGENERATION["NEURODEGENERATION"] -->|"associated with"| SQSTM1["SQSTM1"]
    LYSOSOME["LYSOSOME"] -->|"activates"| SQSTM1["SQSTM1"]
    AUTOPHAGY["AUTOPHAGY"] -->|"activates"| SQSTM1["SQSTM1"]
    BECN1["BECN1"] -->|"activates"| SQSTM1["SQSTM1"]
    LC3["LC3"] -->|"activates"| SQSTM1["SQSTM1"]
    P62["P62"] -->|"activates"| SQSTM1["SQSTM1"]
    OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| SQSTM1["SQSTM1"]
    ROS["ROS"] -->|"activates"| SQSTM1["SQSTM1"]
    AMPK["AMPK"] -->|"activates"| SQSTM1["SQSTM1"]
    ALS["ALS"] -->|"activates"| SQSTM1["SQSTM1"]
    style KEAP1 fill:#ce93d8,stroke:#333,color:#000
    style SQSTM1 fill:#ce93d8,stroke:#333,color:#000
    style MITOPHAGY fill:#ce93d8,stroke:#333,color:#000
    style PARKINSON_S_DISEASE fill:#ef5350,stroke:#333,color:#000
    style AUTOPHAGY fill:#ce93d8,stroke:#333,color:#000
    style MTOR fill:#ce93d8,stroke:#333,color:#000
    style NEURODEGENERATION fill:#ce93d8,stroke:#333,color:#000
    style LYSOSOME fill:#ce93d8,stroke:#333,color:#000
    style BECN1 fill:#ce93d8,stroke:#333,color:#000
    style LC3 fill:#ce93d8,stroke:#333,color:#000
    style P62 fill:#ce93d8,stroke:#333,color:#000
    style OXIDATIVE_STRESS fill:#ce93d8,stroke:#333,color:#000
    style ROS fill:#ce93d8,stroke:#333,color:#000
    style AMPK fill:#ce93d8,stroke:#333,color:#000
    style ALS fill:#ef5350,stroke:#333,color:#000